These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 213009

  • 1. Human platelet aggregation and cAMP system--cAMP level, adenyl cyclase, phosphodiesterase.
    Wang TY, Hussey CV, Sasse EA, Fobian JE.
    Ann Clin Lab Sci; 1978; 8(5):403-12. PubMed ID: 213009
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Functional pool of cyclic adenosine 3',5'-monophosphate in rabbit platelets.
    Hashimoto S.
    Thromb Haemost; 1983 Feb 28; 49(1):8-12. PubMed ID: 6302940
    [Abstract] [Full Text] [Related]

  • 6. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
    Alvarez R, Taylor A, Fazzari JJ, Jacobs JR.
    Mol Pharmacol; 1981 Sep 28; 20(2):302-9. PubMed ID: 6272089
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M, Welzel D, Wolf H, Honey A, Kakkar VV.
    Arzneimittelforschung; 1987 Jun 28; 37(6):669-74. PubMed ID: 2822055
    [Abstract] [Full Text] [Related]

  • 9. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH, Haslam RJ.
    Mol Pharmacol; 1990 May 28; 37(5):671-81. PubMed ID: 2160060
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM, Holmsen H.
    Thromb Haemost; 1984 Dec 29; 52(3):333-5. PubMed ID: 6099615
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ, Rosson GM.
    Mol Pharmacol; 1975 Sep 29; 11(5):528-44. PubMed ID: 170501
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dependence of platelet adenyl cyclase system on oxidative phosphorylation.
    Hashimoto S, Shibata S, Kobayashi B.
    Thromb Diath Haemorrh; 1975 Sep 30; 34(1):42-9. PubMed ID: 171798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.